Arrowhead Pharmaceuticals <ARWR.O>: Piper Sandler raises target price to $126 from $110
ARWR•Related News
TKO director Nick Khan disposes of USD 4.24 million in Class A common shares
TKO•
Northrop Grumman <NOC.N>: JP Morgan cuts target price to $600 from $635
NOC•
Pegasystems Inc <PEGA.O>: Barclays cuts target price to $39 from $48
PEGA•
Guotai Asset Management flags North America cloud earnings as key risk for AI-linked communications stocks
XLC•
Texas Instruments Inc <TXN.O>: JP Morgan raises target price to $340 from $280
TXN•